Absorb GT1: A better future for more patients

Improved ease of use1 and broad patient applicability
Proven safety and efficacy with over 100,0002 patients treated
Restored vessel function3 and reduced late events4

For more product information, visit www.AbsorbGT1.com

1. Improved as compared to Absorb BVS. Tests performed by and data on file at Abbott Vascular; 2. Based on worldwide device utilization rate. Data on file at Abbott Vascular as of April 2015; 3. De Bruyne B, Serruys PW, et al., for the ABSORB Cohort B Investigators, TCT 2014; 4. Smits P. EXTEND 3 Year Presentation. Presented at TCT 2014, 13-17 Sep 2014, Washington, DC.

Abbott Vascular International BVBA,
Park Lane, Culliganlaan 2B, B-1831 Diegem, Belgium, Tel: +32 2 714 14 11.

Caution: This product is intended for use by or under the direction of a physician. Prior to use, reference the Instructions for use provided inside the product carton (when available) or at www.abbottvascular.com/ifu for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Information contained herein for distribution outside the U.S. only. Please check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force. Absorb GT1 is a trademark of the Abbott Group of Companies. www.abbottvascular.com

©2015 Abbott. All rights reserved. AP2941077-OUS Rev. A

Restore freedom - Abbott